Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3823_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
15 Мб
Скачать
☆
difference in all cause mortality or aortic‐related mortality between the two groups, and the risk of the combined secondary outcome of rupture and progression of disease was the same.
Penetrating aortic ulcer (PAU) and Intramural hemorrhage (IMH): PAU and intramural hematoma are two entities that are separate from TBAD but may present with similar symptoms of acute chest/back pain associated with hypertension. Some believe that the three entities are on the same spectrum of disease; however, the natural progression between the three pathologies is unknown. A PAU, as the name implies, is an atherosclerotic ulcer on the aortic wall that erodes into the aortic wall, whereas an intramural hematoma is a collection of blood between the intima and the media. The natural history of these pathologies is not as well understood as dissection, and thus the indications for and timing of surgical intervention are still under investigation.
Contraindications/Caveats
In patients with ideal anatomy, TEVAR seems to be the preferred option for most cases, with current literature demonstrating reduced morbidity and mortality. However, data regarding long‐term (lifelong) follow‐up for TEVAR patients is scarce. In younger, healthier patients with a longer life expectancy, consideration can be made for open repair. As stated previously, the presence of challenging anatomy, such as involvement of major aortic branches, large diameter neck, significant angulation, or circumferential thrombus within the seal zones, may make endovascular repair more difficult. In these cases, a careful risk–benefit assessment must be made, taking into account patient comorbidities and surgeon experience. Endovascular stent grafting for infected TAA is not recommended, but can be considered for patients who are poor surgical candidates.
Available Endografts
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
1. Cook Zenith Alpha (Figure 4.2): A. Stent/graft material:
Nitinol Tightly woven Dacron
B. Lengths (cm):
Proximal straight: 10.5–23.3 Proximal with 4 mm taper: 10.8–23.3 Distal: 14.2–21.1 Distal extension: 9.1–11.2
C. Diameter (mm):
Straight proximal: 24–46 Proximal with 4 mm taper: 30–46 Distal: 28–46
D. Delivery sheath (Inner diameter):
16, 18, 20 Fr
E. Instructions for use:
Isolated lesions of the descending thoracic aorta having vascular anatomy suitable for endovascular repair:
Iliac/femoral anatomy that is suitable for access with the required introduction systems
Nonaneurysmal aortic segments (fixation sites) proximal and distal to the thoracic lesion
Length of at least 20 mm Diameter measured outer wall to outer
wall of no greater than 42 mm and no less than 15 mm.
Figure 4.2 Cook Zenith Alpha Graft.
2. Cook TX2 Dissection Graft (Figure 4.3): A. Stent/graft material:
Stainless steel Standard Dacron
B. Lengths (cm):
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Straight proximal: 7.9–21.8 Proximal with 4 mm taper: 15.4–21 Proximal with 8 mm taper: 15.6–21
C. Diameter (mm):
Proximal straight: 22–42
Figure 4.3 Cook TX2 graft and dissection
stent.
Proximal with 4 mm taper: 32–42 Proximal with 8 mm taper: 32–42
D. Delivery sheath (Inner diameter*):
20–22 Fr
E. Instructions for use:
Treatment of patients with atherosclerotic aneurysms, symptomatic acute or chronic dissections, contained ruptures, growing aneurysms, and/or resulting in distal ischemia, in the descending thoracic aorta having vascular morphology suitable for endovascular repair:
Adequate iliac/femoral access compatible with the required introduction systems
Radius of curvature greater than 35 mm along the entire length of aorta intended to be treated
Nonaneurysmal aortic segments (fixation sites) proximal and distal to the aneurysm:
With a length of at least 20 mm With a diameter measured outer
wall to outer wall of no greater than 38 mm and no less than 20 mm
With an angle less than 45°.
3. Cook TX2 Dissection Stent: A. Stent material
Nitinol
B. Lengths (cm):
8, 12, 18, 18.5
C. Diameters (mm):
36, 46
D. Delivery sheath (Inner diameter*)
16 Fr
E. Instructions for use:
Intended to be used as a distal component to provide support to delaminated segments of nonaneurysmal aorta with dissection distal to a Zenith TX2 Dissection Endovascular Graft in the descending thoracic aorta having vascular morphology suitable for endovascular repair:
Aortic fixation site diameter 20–38 mm (measured outer wall to outer wall)
Radius of curvature >35 mm along the length of aorta that is intended to be treated
Localized angulation <45°.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
4. Gore cTAG with Active Control (Figure 4.4): A. Stent/graft material:
Nitinol ePTFE
Figure 4.4 (a) and (b) Gore cTAG
endoprosthesis.
Source: W. L. Gore & Associates, Inc.
B. Lengths (cm):
10, 15, 20
C. Diameter (mm):
Straight: 21, 26, 28, 31, 34, 37, 40, 45 Tapered: 26 × 21, 31 × 26
D. Delivery sheath (Inner diameter):
18, 20, 22, 24 Fr
E. Instructions for use:
Repair of aneurysms of the descending thoracic aorta in patients who have appropriate anatomy:
Adequate iliac/femoral access Aortic inner diameter in the range of 23–
37 mm 2 cm nonaneurysmal aorta proximal and
distal to the aneurysm.
5. Terumo Aortic Relay (Figure 4.5): A. Stent/graft material:
Nitinol PTFE sutures, woven polyester graft
B. Lengths (cm):
Straight: 10, 15, 20, 25 4 mm Tapered: 15, 20, 25
C. Diameter (mm):
Straight: 22–46 Proximal with 4 mm taper: 28–46
D. Delivery sheath (Outer diameter):
22, 23, 24, 25, 26 Fr
E. Instructions for use:
Repair of fusiform aneurysms and saccular aneurysms/penetrating atherosclerotic ulcers in the descending thoracic aorta in patients having appropriate anatomy:
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
Figure 4.5 Terumo relay aortic graft.
Source: Elsevier Inc.
Iliac or femoral access vessel morphology that is compatible with vascular access techniques, devices, and/or accessories
Nonaneurysmal aortic neck diameter in the range of 19–42 mm
Nonaneurysmal proximal aortic neck length between 15 and 25 mm
Nonaneurysmal distal aortic neck length between 25 and 30 mm.
6. Medtronic Valiant (Figure 4.6): A. Stent/graft material:
Nitinol Woven polyester
B. Length (cm):
Straight: 5.5, 6, 10, 17.5, 22.5 Tapered: 17.5, 18.5, 20
C. Diameter (mm):
Straight: 20, 22, 25, 28, 31, 34, 37, 40, 43, 46
Tapered: 25, 28, 31, 34, 37, 40, 43, 46
D. Delivery sheath (Outer diameter):
18, 20, 22 Fr
E. Instructions for use:
Repair of all lesions of the descending thoracic aorta in patients having the appropriate anatomy:
Iliac or femoral artery access vessel morphology that is compatible with vascular access techniques, devices, or accessories
Figure 4.6 Medtronic valiant thoracic
endograft.
Source: Vascular News.
Nonaneurysmal aortic diameter in the range of 18–42 mm (fusiform and saccular
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
aneurysms/penetrating ulcers), or 18–44 mm (blunt traumatic aortic injuries), or 20–44 mm (dissections)
Nonaneurysmal aorta proximal and distal neck lengths ≥20 mm (fusiform and saccular aneurysms/penetrating ulcers), landing zone ≥20 mm proximal to the primary entry tear (blunt traumatic aortic injuries, dissections)
The proximal extent of the landing zone must not be dissected.
Preoperative Evaluation
The evaluation of the patient with TAA should begin with a thorough history and physical examination. In particular, history of cardiac, pulmonary, and renal disease should be elicited. Routine preoperative laboratory testing, EKG, and chest radiography should be performed.
Cardiac evaluation: Due to the advanced age of the population and prevalence of atherosclerotic risk factors, a significant number of patients with TAA/TAAA have concomitant cardiac disease. Preoperative echocardiogram can be useful for assessing myocardial and valvular function; however, the benefit of routine use of cardiac echo in all TEVAR patients is controversial. Patients who have signs or symptoms of cardiac disease should undergo further evaluation to determine the presence and extent of coronary artery disease. If indicated, patients should undergo coronary revascularization prior to or during TEVAR.
Pulmonary evaluation: The presence of COPD is directly associated with increased perioperative mortality after TEVAR. Preoperative testing including pulmonary function tests and arterial blood gas should be routinely performed. Smoking cessation, if applicable, should be encouraged. Compliance to prescribed inhalers should be ensured as this has been directly linked to mortality in TEVAR patients.